TNF Pharmaceuticals (Formerly MyMD Pharmaceuticals) Begins Trading Under New Nasdaq Stock Symbol “TNFA” Effective Before Market Open Today
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 24 2024
0mins
Source: businesswire
Company Name and Stock Symbol Change: TNF Pharmaceuticals, Inc. (formerly MyMD Pharmaceuticals, Inc.) has changed its stock ticker symbol from "MYMD" to "TNFA," effective July 24, 2024, aligning with its focus on developing therapies targeting TNF-alpha for age-related diseases and autoimmune conditions.
Clinical Development Focus: The company is advancing its lead clinical candidate, MYMD-1®, which aims to regulate the immune system by blocking excess TNF-α, and is also developing a second platform, Supera-CBD, to address chronic pain, addiction, and epilepsy.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
